In vitro studies suggest that CLCA1 can act as a tumor suppressor in COAD by hindering the Wnt/beta-catenin signaling pathway and preventing epithelial-mesenchymal transition (EMT) [16]. This evidence concerns the gene CLCA1 and neoplasm.